Patricia A Bradford insider trades: Phio Pharmaceuticals (PHIO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patricia reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | PHIO | ↑ Buy | 6,500 | $1.01 | $7K | Direct | Sep 25, 2026 (1d) |
| Sep 15, 2026 | PHIO | ↑ Buy | 12,000 | $1.03 | $12K | Direct | Sep 16, 2026 (1d) |
| Jan 31, 2008 | UIS | ↑ Buy | 1,000 | $4.25 | $4K | Direct | Feb 4, 2008 (4d) |
| Feb 16, 2007 | UIS | ↓ Sell | 5,500 | $9.29 | $51K | Direct | Feb 20, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PHIO insiders
Open-market trades in the last 12 months
About Patricia A Bradford's insider trades
Patricia A Bradford is a director at Phio Pharmaceuticals (PHIO). Since Feb 16, 2007, Patricia has reported 3 open-market purchases worth $23K and 1 sale worth $51K on SEC Form 4. In the last 12 months: 2 buys ($19K).
Their filings also include grants and awards (15 filings), shares withheld for taxes (9 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.